Amalgamated Bank Fortress Biotech, Inc. Transaction History

Amalgamated Bank

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 15, 2022	SELL	$0.8 - $1.5 $9,694 - $18,177	-12,118 Closed	0 $0
Q1 2022 Jun 30, 2022	SELL	$1.24 - $2.75 $1,078 - $2,392	-870 Reduced 6.7%	12,118 $16,000
Q4 2021 Feb 15, 2022	SELL	$2.42 - $3.65 $244 - $368	-101 Reduced 0.77%	12,988 $32,000
Q3 2021 Oct 29, 2021	SELL	$2.82 - $3.7 $1,235 - $1,620	-438 Reduced 3.24%	13,089 $42,000
Q2 2021 Aug 16, 2021	BUY	$3.5 - $5.48 $47,344 - $74,127	13,527 New	13,527 $48,000

862K

Ticker FBIO
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 107,735,000
Market Cap $185M
Description
Fortress Biotech, Inc., a biopharmaceutical company, develops and commercializes pharmaceutical and biotechnology products. The company markets dermatology products, such as Ximino capsules to treat only inflammatory lesions of non-nodular moderate to severe acne vulgaris; Targadox for severe acne; Exelderm cream for ringworm and jock itch sympt...

Get notified when there are updates to the investment portfolio of Amalgamated Bank, based on Form 13F filings with the SEC.

Stay updated on Amalgamated Bank with notifications on news.